Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News

Table of Contents

Editorial

  • Editorial
    Evaluation of the Whole Prostaglandin Biosynthetic Pathway in Lung Cancer
    Raymond N. DuBois
    Clin Cancer Res May 1 2003 9 (5) 1577-1578;

Minireview

  • Minireview
    Clinical Trial Design and End Points for Epidermal Growth Factor Receptor-targeted Therapies
    Carlos L. Arteaga and Jose Baselga
    Clin Cancer Res May 1 2003 9 (5) 1579-1589;

The Biology Behind

  • The Biology Behind
    Tumors and Their Microenvironments: Tilling the Soil
    Jonathan D. Cheng and Louis M. Weiner
    Clin Cancer Res May 1 2003 9 (5) 1590-1595;

Advances in Brief

  • Clinical Trials

    • Advances in Brief
      Reactivation of Tumor Suppressor Genes by the Cardiovascular Drugs Hydralazine and Procainamide and Their Potential Use in Cancer Therapy
      Blanca Segura-Pacheco, Catalina Trejo-Becerril, Enrique Perez-Cardenas, Lucia Taja-Chayeb, Ignacio Mariscal, Alma Chavez, Carmen Acuña, Ana Maria Salazar, Marcela Lizano and Alfonso Dueñas-Gonzalez
      Clin Cancer Res May 1 2003 9 (5) 1596-1603;

  • Molecular Oncology, Markers, Clinical Correlates

    • Advances in Brief
      Immunohistochemical Expression of Cyclooxygenase Isoenzymes and Downstream Enzymes in Human Lung Tumors
      Leander Ermert, Christian Dierkes and Monika Ermert
      Clin Cancer Res May 1 2003 9 (5) 1604-1610;

    • Advances in Brief
      Methylenetetrahydrofolate Reductase Polymorphism in Advanced Colorectal Cancer
      Victor Cohen, Valerie Panet-Raymond, Nelly Sabbaghian, Isabelle Morin, Gerald Batist and Rima Rozen
      Clin Cancer Res May 1 2003 9 (5) 1611-1615;

  • Experimental Therapeutics, Preclinical Pharmacology

    • Advances in Brief
      Differential Gene Expression Profiles in a Human T-cell Line Stimulated with a Tumor-associated Self-peptide versus an Enhancer Agonist Peptide
      Claudia Palena, Jeffrey Schlom and Kwong-Yok Tsang
      Clin Cancer Res May 1 2003 9 (5) 1616-1627;

Regular Articles

  • Clinical Trials

    • Regular Articles
      Phase I Study of TLK286 (Glutathione S-Transferase P1-1 Activated Glutathione Analogue) in Advanced Refractory Solid Malignancies
      Lee S. Rosen, Joseph Brown, Bernadette Laxa, Leny Boulos, Laura Reiswig, William D. Henner, Robert T. Lum, Steve R. Schow, Christopher A. Maack, James G. Keck, Julie C. Mascavage, Jacqueline A. Dombroski, Reinaldo F. Gomez and Gail L. Brown
      Clin Cancer Res May 1 2003 9 (5) 1628-1638;

    • Regular Articles
      A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer
      Andrew M. Scott, Greg Wiseman, Sydney Welt, Alex Adjei, Fook-Thean Lee, Wendie Hopkins, Chaitan R. Divgi, Lorelei H. Hanson, Paul Mitchell, Denise N. Gansen, Steven M. Larson, James N. Ingle, Eric W. Hoffman, Paul Tanswell, Gerd Ritter, Leonard S. Cohen, Peter Bette, Lisa Arvay, Andree Amelsberg, Dan Vlock, Wolfgang J. Rettig and Lloyd J. Old
      Clin Cancer Res May 1 2003 9 (5) 1639-1647;

    • Regular Articles
      Efficacy and Toxicity of the Angiogenesis Inhibitor SU5416 As a Single Agent in Patients with Advanced Renal Cell Carcinoma, Melanoma, and Soft Tissue Sarcoma
      Bart C. Kuenen, Jose Tabernero, Jose Baselga, Franco Cavalli, Elisabeth Pfanner, Pier Franco Conte, Siegfried Seeber, Srinivasan Madhusudan, Gael Deplanque, Holgen Huisman, Paul Scigalla, Klaas Hoekman and Adrian L. Harris
      Clin Cancer Res May 1 2003 9 (5) 1648-1655;

    • Regular Articles
      Chronic Lymphocytic Leukemia-reactive T Cells during Disease Progression and after Autologous Tumor Cell Vaccines
      Elena Gitelson, Caitlin Hammond, Jenny Mena, Maria Lorenzo, Rena Buckstein, Neil L. Berinstein, Kevin Imrie and David E. Spaner
      Clin Cancer Res May 1 2003 9 (5) 1656-1665;

    • Regular Articles
      Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer
      Bruce G. Redman, Peg Esper, Quintin Pan, Rodney L. Dunn, Hero K. Hussain, Thomas Chenevert, George J. Brewer and Sofia D. Merajver
      Clin Cancer Res May 1 2003 9 (5) 1666-1672;

    • Regular Articles
      Phase I Evaluation of Sequential Topoisomerase Targeting with Irinotecan/Cisplatin Followed by Etoposide in Patients with Advanced Malignancy
      Edward J. Licitra, Viral Vyas, Kathy Nelson, Rita Musanti, Stephanie Beers, Cecilia Thomas, Elizabeth Poplin, Sharon Smith, Yong Lin, Larry. J. Schaaf, Joseph Aisner, Murugesan Gounder, Rajeev Rajendra, Ahamed Saleem, Deborah Toppmeyer and Eric H. Rubin
      Clin Cancer Res May 1 2003 9 (5) 1673-1679;

    • Regular Articles
      Thalidomide Metabolites in Mice and Patients with Multiple Myeloma
      Jun Lu, Brian D. Palmer, Phillip Kestell, Peter Browett, Bruce C. Baguley, George Muller and Lai-Ming Ching
      Clin Cancer Res May 1 2003 9 (5) 1680-1688;

    • Regular Articles
      Multicenter Randomized Phase II Study of Paclitaxel (1-Hour Infusion), Fluorouracil, Hydroxyurea, and Concomitant Twice Daily Radiation with or without Erythropoietin for Advanced Head and Neck Cancer
      Fred R. Rosen, Daniel J. Haraf, Merrill S. Kies, Kerstin Stenson, Louis Portugal, Marcy A. List, Bruce E. Brockstein, Bharat B. Mittal, Alfred W. Rademaker, Mary Ellyn Witt, Harold Pelzer, Ralph R. Weichselbaum and Everett E. Vokes
      Clin Cancer Res May 1 2003 9 (5) 1689-1697;

    • Regular Articles
      Induction Docetaxel and Carboplatin Followed by Weekly Docetaxel and Carboplatin with Concurrent Radiotherapy, then Surgery in Stage III Non-Small Cell Lung Cancer
      Lori J. Wirth, Joan Lucca, Patricia Ostler, Panos Fidias, Cathy Lynch, Pasi A. Jänne, Roy S. Herbst, Bruce E. Johnson, David J. Sugarbaker, Douglas J. Mathisen, Jeanne M. Lukanich, Noah C. Choi, Stuart M. Berman and Arthur T. Skarin
      Clin Cancer Res May 1 2003 9 (5) 1698-1704;

  • Molecular Oncology, Markers, Clinical Correlates

    • Regular Articles
      Cytochrome P450 and Glutathione Transferase Expression in Human Breast Cancer
      Basil F. El-Rayes, Shadan Ali, Lance K. Heilbrun, Samir Lababidi, David Bouwman, David Visscher and Philip A. Philip
      Clin Cancer Res May 1 2003 9 (5) 1705-1709;

    • Regular Articles
      Differential Splicing of KLK5 and KLK7 in Epithelial Ovarian Cancer Produces Novel Variants with Potential as Cancer Biomarkers
      Ying Dong, Aneel Kaushal, Maria Brattsand, Jim Nicklin and Judith A. Clements
      Clin Cancer Res May 1 2003 9 (5) 1710-1720;

    • Regular Articles
      Serum CYFRA 21-1 in Advanced Stage Non-Small Cell Lung Cancer
      Robin T. Vollmer, Ramaswamy Govindan, Stephen L. Graziano, Gary Gamble, Jennifer Garst, Michael J. Kelley and Robert H. Christenson
      Clin Cancer Res May 1 2003 9 (5) 1728-1733;

    • Regular Articles
      Expression of Thrombospondin-derived 4N1K Peptide-containing Proteins in Renal Cell Carcinoma Tissues Is Associated with a Decrease in Tumor Growth and Angiogenesis
      Yasuyoshi Miyata, Shigehiko Koga, Kousuke Takehara, Hiroshi Kanetake and Shigeru Kanda
      Clin Cancer Res May 1 2003 9 (5) 1734-1740;

    • Regular Articles
      Expression of Cyclooxygenase-2 in Renal Cell Carcinoma
      Yasuyoshi Miyata, Shigehiko Koga, Shigeru Kanda, Masaharu Nishikido, Tomayoshi Hayashi and Hiroshi Kanetake
      Clin Cancer Res May 1 2003 9 (5) 1741-1749;

    • Regular Articles
      Skp2 Overexpression Is a Prognostic Factor in Patients with Ovarian Adenocarcinoma
      Kazushi Shigemasa, Lijun Gu, Timothy J. O’Brien and Koso Ohama
      Clin Cancer Res May 1 2003 9 (5) 1756-1763;

    • Regular Articles
      Overexpression of CDC25A Phosphatase Is Associated with Hypergrowth Activity and Poor Prognosis of Human Hepatocellular Carcinomas
      Xundi Xu, Hirofumi Yamamoto, Masato Sakon, Masayoshi Yasui, Chew Yee Ngan, Hiroki Fukunaga, Tetsushi Morita, Minoru Ogawa, Hiroaki Nagano, Shoji Nakamori, Mitsugu Sekimoto, Nariaki Matsuura and Morito Monden
      Clin Cancer Res May 1 2003 9 (5) 1764-1772;

    • Regular Articles
      Promoter Methylation of INK4a/ARF As Detected in Bile-Significance for the Differential Diagnosis in Biliary Disease
      Bodo Klump, Chih-Jen Hsieh, Stephan Dette, Karlheinz Holzmann, Ralf Kieβlich, Michael Jung, Udo Sinn, Marianne Ortner, Rainer Porschen and Michael Gregor
      Clin Cancer Res May 1 2003 9 (5) 1773-1778;

    • Regular Articles
      RECK Expression in Pancreatic Cancer
      Toshihiko Masui, Ryuichiro Doi, Takatomo Koshiba, Koji Fujimoto, Shoichiro Tsuji, Sanae Nakajima, Masayuki Koizumi, Eiji Toyoda, Sidhartha Tulachan, Daisuke Ito, Kazuhiro Kami, Tomohiko Mori, Michihiko Wada, Makoto Noda and Masayuki Imamura
      Clin Cancer Res May 1 2003 9 (5) 1779-1784;

    • Regular Articles
      Classification of Follicular Thyroid Tumors by Molecular Signature
      Catherine B. Barden, Katherine W. Shister, Baixin Zhu, Gerardo Guiter, David Y. Greenblatt, Martha A. Zeiger and Thomas J. Fahey III
      Clin Cancer Res May 1 2003 9 (5) 1792-1800;

    • Regular Articles
      β-Catenin-related Anomalies in Apoptosis-resistant and Hormone-refractory Prostate Cancer Cells
      Alexandre de la Taille, Mark A. Rubin, Min-Wei Chen, Francis Vacherot, Sixtina Gil-Diez de Medina, Martin Burchardt, Ralph Buttyan and Dominique Chopin
      Clin Cancer Res May 1 2003 9 (5) 1801-1807;

    • Regular Articles
      Gain of Chromosome 8q23–24 Is a Predictive Marker for Lymph Node Positivity in Colorectal Cancer
      B. Michael Ghadimi, Marian Grade, Torsten Liersch, Claus Langer, Alexander Siemer, László Füzesi and Heinz Becker
      Clin Cancer Res May 1 2003 9 (5) 1808-1814;

  • Molecular Oncolology, Markers, Clinical Correlates

    • Regular Articles
      Characterization of Human Lymphocyte Antigen Class I Antigen-processing Machinery Defects in Renal Cell Carcinoma Lesions with Special Emphasis on Transporter-associated with Antigen-processing Down-Regulation
      Barbara Seliger, Derek Atkins, Michaela Bock, Ulrike Ritz, Soldano Ferrone, Christoph Huber and Stefan Störkel
      Clin Cancer Res May 1 2003 9 (5) 1721-1727;

    • Regular Articles
      The Gene Ratios c-MYC:Cyclin-dependent Kinase (CDK)N2A and CCND1:CDKN2A Correlate with Poor Prognosis in Squamous Cell Carcinoma of the Head and Neck
      Jan Akervall, Ulrike Bockmühl, I. Petersen, Kun Yang, Thomas E. Carey and David M. Kurnit
      Clin Cancer Res May 1 2003 9 (5) 1750-1755;

    • Regular Articles
      Lack of Interleukin-10 Expression Could Predict Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer
      Jean-Charles Soria, Chulso Moon, Bonnie L. Kemp, Diane D. Liu, Lei Feng, Ximing Tang, Yoon-Soo Chang, Li Mao and Fadlo R. Khuri
      Clin Cancer Res May 1 2003 9 (5) 1785-1791;

    • Regular Articles
      The Loss of 5α-Reductase Type I and Type II mRNA Expression in Metastatic Prostate Cancer to Bone and Lymph Node Metastasis
      Fouad K. Habib, Margaret Ross, Colin W. Bayne, Prasad Bollina, Ken Grigor and Karen Chapman
      Clin Cancer Res May 1 2003 9 (5) 1815-1819;

  • Experimental Therapeutics, Preclinical Pharmacology

    • Regular Articles
      Stroma Cells
      Chiara Corsini, Patrizia Mancuso, Saki Paul, Alessandra Burlini, Giovanni Martinelli, Giancarlo Pruneri and Francesco Bertolini
      Clin Cancer Res May 1 2003 9 (5) 1820-1825;

    • Regular Articles
      Effect of Interleukin (IL)-4 Cytotoxin on Breast Tumor Growth after in Vivo Gene Transfer of IL-4 Receptor α Chain
      Koji Kawakami, Mariko Kawakami, Syed R. Husain and Raj K. Puri
      Clin Cancer Res May 1 2003 9 (5) 1826-1836;

    • Regular Articles
      Vaccine Therapy of Established Tumors in the Absence of Autoimmunity
      James W. Hodge, Douglas W. Grosenbach, Wilhelmina M. Aarts, Diane J. Poole and Jeffrey Schlom
      Clin Cancer Res May 1 2003 9 (5) 1837-1849;

    • Regular Articles
      Identification of HLA-A*0201-restricted Cytotoxic T Lymphocyte Epitope from TRAG-3 Antigen
      Bo Zhu, Zhengtang Chen, Xiaoming Cheng, Zhihua Lin, Jianxiu Guo, Zhengcai Jia, Liyun Zou, Zhixin Wang, Yide Hu, Dongling Wang and Yuzhang Wu
      Clin Cancer Res May 1 2003 9 (5) 1850-1857;

    • Regular Articles
      Administration of Optimal Biological Dose and Schedule of Interferon α Combined with Gemcitabine Induces Apoptosis in Tumor-associated Endothelial Cells and Reduces Growth of Human Pancreatic Carcinoma Implanted Orthotopically in Nude Mice
      Carmen C. Solorzano, Rosa Hwang, Cheryl H. Baker, Corazon D. Bucana, Peter W. Pisters, Douglas B. Evans, Jerald J. Killion and Isaiah J. Fidler
      Clin Cancer Res May 1 2003 9 (5) 1858-1867;

    • Regular Articles
      Specific and High-Level Targeting of Radiolabeled Octreotide Analogues to Human Medulloblastoma Xenografts
      Ganesan Vaidyanathan, Henry S. Friedman, Donna J. Affleck, Margaret Schottelius, Hans-Jürgen Wester and Michael R. Zalutsky
      Clin Cancer Res May 1 2003 9 (5) 1868-1876;

    • Regular Articles
      Cyclin D1 Overexpression Sensitizes Breast Cancer Cells to Fenretinide
      Andreja Pirkmaier, Kally Yuen, Joy Hendley, Matthew J. O’Connell and Doris Germain
      Clin Cancer Res May 1 2003 9 (5) 1877-1884;

    • Regular Articles
      The Cyclooxygenase 2-selective Inhibitor NS398 Inhibits Proliferation of Oral Carcinoma Cell Lines by Mechanisms Dependent and Independent of Reduced Prostaglandin E2 Synthesis
      Helena A. Minter, John W. Eveson, Suzanne Huntley, Douglas J. E. Elder and Angela Hague
      Clin Cancer Res May 1 2003 9 (5) 1885-1897;

    • Regular Articles
      Dual Action of NAMI-A in Inhibition of Solid Tumor Metastasis
      Gianni Sava, Sonia Zorzet, Claudia Turrin, Francesca Vita, MariaRosa Soranzo, Giuliano Zabucchi, Moreno Cocchietto, Alberta Bergamo, Stefano DiGiovine, Gabriella Pezzoni, Luigi Sartor and Spiridione Garbisa
      Clin Cancer Res May 1 2003 9 (5) 1898-1905;

    • Regular Articles
      Novel Kidney Cancer Immunotherapy Based on the Granulocyte- Macrophage Colony-stimulating Factor and Carbonic Anhydrase IX Fusion Gene
      José M. Hernández, Matthew H. T. Bui, Ken-ryu Han, Hideki Mukouyama, Danielo G. Freitas, David Nguyen, Randy Caliliw, Peter I. Shintaku, Sun H. Paik, Cho-Lea Tso, Robert A. Figlin and Arie S. Belldegrun
      Clin Cancer Res May 1 2003 9 (5) 1906-1916;

    • Regular Articles
      In Vitro and in Vivo Antitumor Activity of Methotrexate Conjugated to Human Serum Albumin in Human Cancer Cells
      Katja Wosikowski, Elfi Biedermann, Benno Rattel, Norbert Breiter, Peter Jank, Roland Löser, Gerrit Jansen and Godefridus J. Peters
      Clin Cancer Res May 1 2003 9 (5) 1917-1926;

    • Regular Articles
      Chemoprevention of Benzo(a)pyrene-induced Lung Tumors in Mice by the Farnesyltransferase Inhibitor R115777
      William T. Gunning, Paula M. Kramer, Ronald A. Lubet, Vernon E. Steele, David W. End, Walter Wouters and Michael A. Pereira
      Clin Cancer Res May 1 2003 9 (5) 1927-1930;

    • Regular Articles
      Bcl-2 Antisense (G3139, Genasense) Enhances the in Vitro and in Vivo Response of Epstein-Barr Virus-associated Lymphoproliferative Disease to Rituximab
      Regina Loomis, Rocco Carbone, Michael Reiss and Jill Lacy
      Clin Cancer Res May 1 2003 9 (5) 1931-1939;

Back to top
PreviousNext
Clinical Cancer Research: 9 (5)
May 2003
Volume 9, Issue 5
  • Table of Contents
  • About the Cover
  • Index by Author

Sign up for alerts

Issue Highlights

  • Methylenetetrahydrofolate Reductase Polymorphism in Advanced Colorectal Cancer
  • Differential Gene Expression Profiles in a Human T-cell Line Stimulated with a Tumor-associated Self-peptide versus an Enhancer Agonist Peptide
  • Reactivation of Tumor Suppressor Genes by the Cardiovascular Drugs Hydralazine and Procainamide and Their Potential Use in Cancer Therapy

Jump to

  • Editorial
  • Minireview
  • The Biology Behind
  • Advances in Brief
    • Clinical Trials
    • Molecular Oncology, Markers, Clinical Correlates
    • Experimental Therapeutics, Preclinical Pharmacology
  • Regular Articles
    • Clinical Trials
    • Molecular Oncology, Markers, Clinical Correlates
    • Molecular Oncolology, Markers, Clinical Correlates
    • Experimental Therapeutics, Preclinical Pharmacology
Advertisement
  • Most Cited
  • Most Read
Loading
  • Hyperprogressive Disease with Anti-PD-1/PD-L1 Therapy
  • Multiplex Genome Editing to Generate Universal CAR T Cells
  • Integrated Safety Analysis of Urelumab
  • Genomics of Immunotherapy-Associated Hyperprogressors
  • Translational Genomics in Breast Cancer
More...
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement